Active Supportive Care and Symptom Management Grants
| PI Name | Organization - Company | Title |
FOA |
|---|---|---|---|
| Mosher, Catherine E | Indiana Univ-Purdue Univ At Indianapolis | Acceptance and Commitment Therapy for Fatigue Interference in Metastatic Breast Cancer | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Shelby, Rebecca A | Duke University | Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Perkins, Susan M | Indiana Univ-Purdue Univ At Indianapolis | Evaluation of the Communication Plan Early through End-of-Life (COMPLETE) Intervention | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Mao, Jun J | Sloan-Kettering Inst Can Research | Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE) | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Hui, David | University Of Tx Md Anderson Can Ctr | Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Smith, Ellen Mary Lavoie | University Of Alabama At Birmingham | Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Porter, Laura S | Duke University | Couple Communication Skills Training for Advanced Cancer | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Washington, Karla | Washington University | Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Hui, David | University Of Tx Md Anderson Can Ctr | Strategies for Persistent Agitated Delirium in Palliative Care | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Bylund, Carma L. | University Of Florida | Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators | PAR-18-869: Modular R01s in Cancer Control and Population Sciences |
| Salvemini, Daniela | Saint Louis University | Fingolimod and Ozanimod for the treatment and prevention of chemobrain | PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
| Hanks, Brent Allen | Duke University | Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities | PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
| Geisler, Stefanie | Washington University | Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy | PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
| Geisler, Stefanie | Washington University | Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy | PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
| Krause, Diane S | Yale University | "Exploration of Human Parathyroid Cellular Organization and Function" | PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies |